Thomas Wald, MD
Internal Medicine · Wausau, WINPI 1164438040
Payments from drug & device makers
Across 37 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$147
- Inogen, Inc.$94
- GSK$90
- La Jolla Pharmaceutical Company$83
- Mylan Specialty L.p.$58
- Grifols USA, LLC$48
- plus $170 from 8 others
What the payments were for
- Food & beverage$60788%
- Education$8312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 8 | $147 |
| Inogen, Inc. | 5 | $94 |
| GSK | 5 | $90 |
| La Jolla Pharmaceutical Company | 2 | $83 |
| Mylan Specialty L.p. | 4 | $58 |
| Grifols USA, LLC | 2 | $48 |
| Johnson & Johnson | 3 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Pfizer | 1 | $15 |
| Insmed, Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Philips North America LLC | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$690 in reported general payments places this provider in the 85th percentile of 1,411 internal medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 159 | $103,132 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 11 | $79,575 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 94 | $62,259 |
| TezspireTezepelumab-Ekko | 12 | $52,521 |
| Dupixent SyringeDupilumab | 13 | $48,273 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $45,957 |
| Pirfenidone | 12 | $33,638 |
| Spiriva RespimatTiotropium Bromide | 39 | $31,045 |
| Breo ElliptaFluticasone/Vilanterol | 67 | $29,057 |
| Spiriva HandihalerTiotropium Bromide | 41 | $28,185 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 83 | $16,189 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 20 | $15,061 |
| Incruse ElliptaUmeclidinium Bromide | 24 | $13,899 |
| Arnuity ElliptaFluticasone Furoate | 28 | $10,765 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 231 | $9,435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $90 | $202,809331 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat, Combivent Respimat | $147 | $108,366153 claims |
| Grifols USA, LLCProlastin C | $48 | $79,57511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,411 internal medicine providers in Wisconsin.
Other internal medicine in Wausau
- Daniel KrauseWausau$42K
- Kris LahrenWausau$5K
- Nicholas SiebersMadison$47.3M
- Irene MirkinMiddleton$42.9M
- John BlanchardMadison$17.2M
- Carlos SanabriaWest Bend$12.9M
- Andrew KimWauwatosa$2.3M
- Jeremiah DeptaMilwaukee$2.2M
- Gilbert JenouriMilwaukee$2.2M
- Stephen FlachMadison$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.